Heart failure (HF) is a major cause of morbidity and mortality with more than 5.1 million
individuals affected in the USA. Ventricular tachyarrhythmias (VAs) including ventricular …

Background: The reliability of intrathoracic impedance monitoring for prediction of heart
failure (HF) by implantable cardiac devices is controversial. Despite using additional device …

Abstract Aims The HeartLogic multisensor index has been found to be a sensitive predictor
of worsening heart failure (HF). However, there is limited data on this index's association …

Introduction Thoracic impedance (TI) drops measured by implantable cardioverter‐
defibrillators (ICDs) have been reported to correlate with ventricular tachycardia/fibrillation …

Background and purpose Advances of implantable cardioverter–defibrillator (ICD) devices
allow correlating changes in the intra-thoracic impedance (TI), an indicator of fluid overload …

Abstract Background Ventricular arrhythmias (VAs) are independently related to mortality
risk in patients with heart failure (HF). The wide availability of implantable cardioverter …

In patients with symptomatic chronic heart failure (HF) the first line therapy consists of the
pharmacological treatment with neurohormonal antagonists. Digitalis glycosides are also …

In patients with symptomatic chronic heart failure (HF) the first line therapy consists of the
pharmacological treatment with neurohormonal antagonists. Digitalis glycosides are also …

Heart failure (HF) care is demanding and expensive. Despite major advances in drug and
device therapies as well as better detection and management of heart failure (HF) at earlier …